Even before the Wuhan coronavirus (COVID-19) pandemic, American citizens were advised by health officials, Big Pharma and mainstream media to "trust science." But an audit of trials funded by the National Institutes of Health (NIH) revealed that majority of them were not able to meet federal requirements.
In August last year, the Department of Health and Human Services released the results of an audit that was conducted to determine whether the NIH ensured that the Intramural and Extramural clinical trials it funded have complied with Federal reporting requirements.
According to the Office of Inspector General (OIG), the NIH is responsible for ensuring that NIH-funded Intramural and Extramural clinical trials are reported on the public website ClinicalTrials.gov.
Posting the results of clinical trials on ClinicalTrials.gov provides the public information that is available for understanding the safety and effectiveness of interventions.
The OIG specifically examined all 72 NIH-funded Intramural and Extramural clinical trials "for which Federal law and NIH policy required the results to be reported in calendar year 2019 or 2020."
It's not if any of the 72 studies involved COVID-19-related interests, such as vaccine trials. Below are the OIG's findings:
- More than 50 percent of the studies audited (37 out of 72) were non-compliant with federal reporting requirements.
- 12 of the studies submitted their results late.
- 25 of the studies never submitted their results.
Not posting study findings is one way to cover negative results about intervention safety and effectiveness. This practice is called publication bias, or "the failure to publish the results of a study on the basis of the direction or strength of the study findings," said the NIH. (Related: Clinical trials for mRNA FLU SHOTS already underway.)
The OIG summarized other key findings from their audit, which include:
- The NIH did not always check if responsible parties submitted clinical trial results.
- The NIH did not have adequate procedures to confirm that responsible parties for NIH-funded clinical trials adhered to federal reporting guidelines.
- The benefits (and risks) of clinical trials may not be fully realized when federal reporting requirements are not met.
Audit revelations regarding past NIH-funded research highlight government failures during COVID-19 pandemic
The audit was conducted because the OIG's preliminary review of data from ClinicalTrials.gov revealed that "the results of most NIH-funded clinical trials that were completed in calendar year 2018 were not posted."
This realization of clinical trial failures highlights the shocking but not surprising admission by Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC).
In a video recently distributed to CDC employees about the agency’s inept handling of the COVID-19 pandemic, Walensky said: "To be frank, we are responsible for some pretty dramatic, pretty public mistakes, from testing to data to communications."
If the CDC's director herself knows the agency is making mistakes, it shouldn't be surprising that the public refuses to blindly trust the alleged "science" behind COVID-19 vaccines.
Go to Vaccines.news for more information about COVID-19 vaccines.
Watch the video below to know more about how an Indiana doctor exposed the CDC's COVID-19 mandate fraud.
This video is from the Heaven Reigns channel on Brighteon.com.
More related stories:
Clinical trials begin for medical patch that can administer COVID-19 vaccines through the skin.
Pfizer, FDA hid data showing clinical trials failed, says former BlackRock advisor.
Sources include:
OIG.hhs.gov[PDF]
Please contact us for more information.